| Fluoxetine | Approved Investigational Vet Approved | WIPI1 | 55062 |
upregulated | Fluoxetine results in increased expression of WIPI1 mRNA | 17q24.2 | |
| Fluphenazine | Approved | TAC1 | 6863 |
downregulated | Fluphenazine results in decreased expression of TAC1 mRNA | 7q21.3 | |
| Flurbiprofen | Approved Investigational | HPGD | 3248 |
upregulated | Flurbiprofen results in increased expression of HPGD mRNA | 4q34.1 | |
| Flurbiprofen | Approved Investigational | MMP9 | 4318 |
downregulated | Flurbiprofen results in decreased expression of MMP9 mRNA | 20q13.12 | |
| Flurbiprofen | Approved Investigational | MMP9 | 4318 |
downregulated | [Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA | 20q13.12 | |
| Flurbiprofen | Approved Investigational | NGFR | 4804 |
upregulated | Flurbiprofen results in increased expression of NGFR mRNA | 17q21.33 | |
| Flurbiprofen | Approved Investigational | NGFR | 4804 |
upregulated | Flurbiprofen results in increased stability of and results in increased expression of NGFR mRNA | 17q21.33 | |
| Flurbiprofen | Approved Investigational | PTGS2 | 5743 |
upregulated | Flurbiprofen results in increased expression of PTGS2 mRNA | 1q31.1 | |
| Flutamide | Approved Investigational | ABCB1 | 5243 |
upregulated | [Flutamide results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Flutamide | Approved Investigational | CYP3A4 | 1576 |
upregulated | Flutamide results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Flutamide | Approved Investigational | ESR1 | 2099 |
upregulated | Flutamide results in increased expression of ESR1 mRNA | 6q25.1-q25.2 | |
| Flutamide | Approved Investigational | ESR2 | 2100 |
upregulated | Flutamide results in increased expression of ESR2 mRNA | 14q23.2-q23.3 | |
| Fluticasone propionate | Approved Investigational | CYP3A5 | 1577 |
upregulated | Fluticasone results in increased expression of CYP3A5 mRNA | 7q22.1 | |
| Fluticasone propionate | Approved Investigational | DUSP1 | 1843 |
upregulated | Fluticasone results in increased expression of DUSP1 mRNA | 5q35.1 | |
| Fluticasone propionate | Approved Investigational | GGT5 | 2687 |
upregulated | Fluticasone results in increased expression of GGT5 mRNA | 22q11.23 | |
| Fluticasone propionate | Approved Investigational | SLPI | 6590 |
upregulated | Fluticasone results in increased expression of SLPI mRNA | 20q13.12 | |
| Fluvastatin | Approved Investigational | CYP2B6 | 1555 |
upregulated | fluvastatin results in increased expression of CYP2B6 mRNA | 19q13.2 | |
| Fluvastatin | Approved Investigational | DDB2 | 1643 |
downregulated | fluvastatin results in decreased expression of DDB2 mRNA | 11p11.2 | |
| Fluvastatin | Approved Investigational | MMP2 | 4313 |
downregulated | fluvastatin results in decreased expression of MMP2 mRNA | 16q12.2 | |
| Fluvastatin | Approved Investigational | MMP9 | 4318 |
downregulated | fluvastatin results in decreased expression of MMP9 mRNA | 20q13.12 | |
| Fluvastatin | Approved Investigational | NOS2 | 4843 |
upregulated | fluvastatin results in increased expression of NOS2 mRNA | 17q11.2 | |
| Fluvastatin | Approved Investigational | SOD2 | 6648 |
downregulated | [fluvastatin results in decreased expression of DDB2] which results in increased expression of SOD2 mRNA | 6q25.3 | |
| Fluvastatin | Approved Investigational | SOD2 | 6648 |
upregulated | fluvastatin results in increased expression of SOD2 mRNA | 6q25.3 | |
| Fluvastatin | Approved Investigational | TFRC | 7037 |
downregulated | fluvastatin results in decreased expression of TFRC mRNA | 3q29 | |
| Folic acid | Approved Investigational Nutraceutical Vet Approved | ABCG2 | 9429 |
upregulated | Folic Acid deficiency results in increased expression of ABCG2 mRNA | 4q22.1 | |